For people with incurable conditions, the uncertain promise of unproven treatments can outweigh the risks. As ‘stem cell tourism’ increases, one research team aims to ensure patients stay well informed – and connected to mainstream support networks.
When she was released from hospital three months after suffering a spinal injury, Natalie (not her real name) had to confront the prospect of spending the rest of her life in a wheelchair.
“I got out fairly depressed, couldn’t believe I was going to spend … life sitting in this chair, after having a fairly active life up until then, and also I was
Warnings are being issued by experts of the dangers of medical tourism saying that unproven stem cell therapy overseas could leave patients worse off.
Signing up for stem cell therapy is worth the risk for many people who are suffering with conditions like spinal injury, multiple sclerosis, motor neuron or Parkinson’s disease.
A medical journal reported earlier this year that an Israeli teenager developed brain tumors after experimental injections at a Russian clinic.
There are alternate reports also of patients contracting meningitis after treatments in China.
A handbook will be released by the Australian Stem Cell Centre to help patients analyze radial stem
The Australian Stem Cell Centre (ASCC) through StemCore, its national facility for the provision of stem cells and advice, continues to build a world class Australian stem cell research community. For the first time in Australia, young researchers will be trained in the techniques of growing and using human induced pluripotent stem (iPS) cells in research.
iPS cells, discovered in 2006 when Japanese scientists reprogrammed ordinary skin cells into versatile stem cells, have made a significant impact on Australian research and are recognised as one of the most important developments in stem cell research in recent times. By
An international team of researchers led by renowned stem cell scientist Professor Martin Pera has discovered a novel marker that plays an important role in our understanding of how cancer develops in the liver, pancreas and oesophagus.
The study, published in the journal Stem Cell, adds to our understanding of the role of stem and next stage progenitor cells in tissue regeneration and in the diagnosis and treatment of cancer.
While stem cells are known to reside in organs such as the liver and pancreas, they are difficult to isolate. The new findings show that an antibody developed by the team